Join the 'Idiopathic (Immune) Thrombocytopenic Purpura' group to help and get support from people like you.
Idiopathic (Immune) Thrombocytopenic Purpura News
Related terms: Immune Thrombocytopenic Purpura, ITP
Posted 18 Apr 2018 by Drugs.com
SOUTH SAN FRANCISCO, Calif., April 17, 2018 /PRNewswire/ – Rigel Pharmaceuticals, Inc. (Nasdaq:RIGL) today announced that the U.S. Food and Drug Administration (FDA) approved Tavalisse (fostamatinib disodium hexahydrate) for the treatment of thrombocytopenia in adult patients with chronic immune thrombocytopenia (ITP) who have had an insufficient response to a previous treatment. Tavalisse is an ...
FDA Extends Use of Promacta (eltrombopag) in Pediatric Patients with Immune Thrombocytopenic Purpura
Posted 24 Aug 2015 by Drugs.com
August 24, 2015 – The U.S. Food and Drug Administration today approved Promacta (eltrombopag) to treat low blood platelet count in pediatric patients – ages one year and older – with a rare blood disorder called chronic immune thrombocytopenic purpura (ITP). Promacta can be used in these children when they have not achieved an appropriate response using other ITP medicines or surgery to remove th ...
Posted 24 Aug 2015 by Drugs.com
MONDAY, Aug. 24, 2015 – U.S. Food and Drug Administration approval of the drug Promacta (eltrombopag) has been expanded to include children one year and older with a rare blood disorder called chronic immune thrombocytopenic purpura (ITP). ITP is characterized by a low blood platelet count. Promacta is now approved for the disorder among children who have had unsatisfactory results with other ...
Posted 14 Jun 2015 by Drugs.com
SAN DIEGO, June 12, 2015 --(BUSINESS WIRE)-- Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announces that the FDA has approved a supplemental New Drug Application (sNDA) for the use of Promacta (eltrombopag), a Novartis product, for the treatment of children six years and older with chronic immune thrombocytopenia (cITP) who have had an insufficient response to corticosteroids, ...
Posted 24 Nov 2008 by Drugs.com
MONDAY, Nov. 24 – The U.S. Food and Drug Administration has approved Promacta (eltrombopag) to treat a rare condition in which the body attacks its own blood platelets. Chronic immune thrombocytopenic purpura (ITP) affects about 60,000 people in the United States, according to a news release from the drug's maker, GlaxoSmithKline. ITP patients often bleed from small blood vessels, resulting in ...
Posted 22 Aug 2008 by Drugs.com
FRIDAY, Aug. 22 – The U.S. Food and Drug Administration has approved Nplate (romiplostim), a drug that stimulates bone marrow to make needed platelets in people with a rare bleeding disorder called immune thrombocytopenic purpura (ITP). The disorder, affecting about 140,000 people in the United States, causes a low count of platelets, a component that helps blood clot. In people with chronic ...
Related Condition Support Groups
Related Drug Support Groups
prednisone, cortisone, triamcinolone, dexamethasone, cyclosporine, rituximab, azathioprine, Decadron, Gammagard, view more... RhoGAM, interferon alfa-2b, Gamunex, Privigen, Nplate, immune globulin intravenous, Deltasone, Promacta, Carimune, Gamunex-C, Intron A, Kenalog-40, Dexone, Carimune NF, Octagam, Adrenocot LA, Sandoglobulin, Sterapred DS, Liquid Pred, Tavalisse, WinRho SDF, Adrenocot, Sterapred, romiplostim, eltrombopag, Rhophylac, De-Sone LA, fostamatinib, Gamimune, HyperRHO S / D Mini-Dose, Liberim D, HyperRHO S / D Full Dose, Partobulin SDF, D-Gam Anti-D, BayRHo-D Mini-Dose, BayRHo-D Full Dose, immune globulin intravenous and subcutaneous, Baycadron, Dexamethasone Intensol, HypRho-D Mini-Dose, Dalalone, Dalalone DP, Dalalone LA, Decaject, Decaject LA, Gammaplex, Gammar IV, Zema Pak, rho (d) immune globulin, Gammaked, Zonacort, LoCort, BayRHo-D, Gamulin Rh, Mini-Gamulin Rh, Prednicot, Dexasone, Dexasone LA, Dexone LA, Primethasone, Dexacorten, Medidex, Medidex LA, Dexpak Taperpak, Solurex, Meticorten, Dexacen-4, Orasone, Prednicen-M, Solurex LA, Cortone Acetate, Dexacort-LA, Decadron-LA, Gammagard S / D, Hexadrol, Venoglobulin-S 5%, Venoglobulin-S 10%, Gammar-P IV, Polygam S / D, Gamimune N 5%, Gamimune N 10%, Panglobulin, Iveegam En, MICRhoGAM, Panglobulin NF, Flebogamma, Clinacort